By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Paced by growth in its Analytical Technologies segment, Thermo Fisher Scientific today reported 3 percent revenue growth year over year in the first quarter.

For the three months ended April 2, the company posted revenues of $2.72 billion, up from $2.63 billion a year ago, and surpassing analyst forecasts for $2.65 billion. Acquisitions added 2 percentage points to revenues, while currency translation added 1 percentage point.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Differences in DNA methylation could be used to distinguish between DNA samples obtained from identical twins, researchers say.

A retrovirus that's been integrated into the human genome appears to have a role in embryonic development, researchers report.

A report from MIT identifies areas of scientific research where declining research support is hindering needed advances.

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.